DLB - Company ID 0001308547
The table below shows Dolby Laboratories, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $395.63M | $346.71M | $315.55M | $369.56M | $357.00M | $288.82M |
| Cost of revenue | $44.73M | $43.21M | $44.00M | $35.84M | $40.77M | $35.66M |
| Gross profit | $350.90M | $303.50M | $271.54M | $333.72M | $316.23M | $253.16M |
| R&D | $63.65M | $69.08M | $65.98M | $61.71M | $66.64M | $65.50M |
Dolby Laboratories, Inc. reported annual revenue of $1.35B for fiscal year 2025. That is up 5.9% from $1.27B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.03B (FY 2016) to $1.35B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $75.95M | $70.24M | $72.31M | $70.42M | $70.09M | $69.28M |
| Operating income | $112.95M | $62.16M | $47.64M | $107.76M | $79.88M | $36.78M |
| Income tax | $24.25M | $17.92M | $8.97M | $28.02M | $17.98M | $10.51M |
| Net income | $94.92M | $53.33M | $46.07M | $91.79M | $67.82M | $38.44M |
| EPS (diluted) | $0.99 | $0.55 | $0.48 | $0.94 | $0.70 | $0.40 |